Please login to the form below

Not currently logged in
Email:
Password:

AbbVie: UK patients want better arthritis care

Study from Humira manufacturer concludes that UK doctors need better collaboration with patients

AbbVie: UK patients want better arthritis care

Almost two-thirds of UK patients with rheumatoid arthritis (RA) do not feel their condition is well managed, according to a new report.

The research, funded by AbbVie, also found that just 26 per cent of UK RA patients say they have a disease management plan in place, compared to 56 per cent globally. 

AbbVie, creator of the world biggest-selling arthritis drug Humira (adalimumab), saidthe global survey “prompts calls for increased collaboration between doctors and patients”.

The findings formed part of 'RA: Join the Fight', a global AbbVie initiative, which presented results from the survey of 10,171 patients from 42 countries at a conference in Madrid.

The anonymous survey also found that patients in the UK who say they have a disease management plan with their healthcare provider were nearly twice as likely to feel hopeful (25 per cent vs 15 per cent) and twice as likely to feel confident (24 per cent vs 10 per cent) about living with their RA over the past week as those who do not have a disease management plan.

In addition, patients who are more involved in the RA community, including those who are members of patient advocacy groups, are more likely to say they know a great deal or moderate amount about RA and visit their healthcare professional more regularly, according to AbbVie.

Tracey Hancock, director of development at the National Rheumatoid Arthritis Society, said: “This important survey confirms what our research has also told us – that living with RA can have a devastating effect on a person and their family. However, it also shows that patients who manage their condition together with their healthcare professional team can lead a better life with RA.”

19th June 2013

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics